Development of acute myeloid leukemia after chemotherapy for osteosarcoma

Akira Kawai, Shinsuke Sugihara, Noriko Naito, Toshihumi Ozaki, Kazuo Isu, Yoshio Hatae, Hajime Inoue

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The current study describes two patients with osteosarcoma who had acute myeloid leukemia develop after treatment with multiagent chemotherapy. The incidence density for the chemotherapy protocol was 129.8 per 10,000 person-year of followup. Karyotype analysis of 16 reported patients (including the current two patients) indicated that most leukemias after treatment of osteosarcoma correlated with the use of topoisomerase II inhibitors, such as doxorubicin. The deoxyribonucleic acid-damaging activity of doxorubicin reinforced by the use of alkylating agents is highly suspected as a causative event in the development of leukemia after treatment of osteosarcoma. As the next step in the development of treatment for patients with osteosarcoma, the type and intensity of treatment must be evaluated to minimize possible leukemogenic effects without compromising the potential for cure.

Original languageEnglish
Pages (from-to)239-246
Number of pages8
JournalClinical Orthopaedics and Related Research
Issue number391
Publication statusPublished - 2001

Fingerprint

Osteosarcoma
Acute Myeloid Leukemia
Drug Therapy
Doxorubicin
Leukemia
Topoisomerase II Inhibitors
Therapeutics
Alkylating Agents
Karyotype
DNA
Incidence

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Kawai, A., Sugihara, S., Naito, N., Ozaki, T., Isu, K., Hatae, Y., & Inoue, H. (2001). Development of acute myeloid leukemia after chemotherapy for osteosarcoma. Clinical Orthopaedics and Related Research, (391), 239-246.

Development of acute myeloid leukemia after chemotherapy for osteosarcoma. / Kawai, Akira; Sugihara, Shinsuke; Naito, Noriko; Ozaki, Toshihumi; Isu, Kazuo; Hatae, Yoshio; Inoue, Hajime.

In: Clinical Orthopaedics and Related Research, No. 391, 2001, p. 239-246.

Research output: Contribution to journalArticle

Kawai, A, Sugihara, S, Naito, N, Ozaki, T, Isu, K, Hatae, Y & Inoue, H 2001, 'Development of acute myeloid leukemia after chemotherapy for osteosarcoma', Clinical Orthopaedics and Related Research, no. 391, pp. 239-246.
Kawai, Akira ; Sugihara, Shinsuke ; Naito, Noriko ; Ozaki, Toshihumi ; Isu, Kazuo ; Hatae, Yoshio ; Inoue, Hajime. / Development of acute myeloid leukemia after chemotherapy for osteosarcoma. In: Clinical Orthopaedics and Related Research. 2001 ; No. 391. pp. 239-246.
@article{956e2b1fe3ca45e5902194342a8e203d,
title = "Development of acute myeloid leukemia after chemotherapy for osteosarcoma",
abstract = "The current study describes two patients with osteosarcoma who had acute myeloid leukemia develop after treatment with multiagent chemotherapy. The incidence density for the chemotherapy protocol was 129.8 per 10,000 person-year of followup. Karyotype analysis of 16 reported patients (including the current two patients) indicated that most leukemias after treatment of osteosarcoma correlated with the use of topoisomerase II inhibitors, such as doxorubicin. The deoxyribonucleic acid-damaging activity of doxorubicin reinforced by the use of alkylating agents is highly suspected as a causative event in the development of leukemia after treatment of osteosarcoma. As the next step in the development of treatment for patients with osteosarcoma, the type and intensity of treatment must be evaluated to minimize possible leukemogenic effects without compromising the potential for cure.",
author = "Akira Kawai and Shinsuke Sugihara and Noriko Naito and Toshihumi Ozaki and Kazuo Isu and Yoshio Hatae and Hajime Inoue",
year = "2001",
language = "English",
pages = "239--246",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "391",

}

TY - JOUR

T1 - Development of acute myeloid leukemia after chemotherapy for osteosarcoma

AU - Kawai, Akira

AU - Sugihara, Shinsuke

AU - Naito, Noriko

AU - Ozaki, Toshihumi

AU - Isu, Kazuo

AU - Hatae, Yoshio

AU - Inoue, Hajime

PY - 2001

Y1 - 2001

N2 - The current study describes two patients with osteosarcoma who had acute myeloid leukemia develop after treatment with multiagent chemotherapy. The incidence density for the chemotherapy protocol was 129.8 per 10,000 person-year of followup. Karyotype analysis of 16 reported patients (including the current two patients) indicated that most leukemias after treatment of osteosarcoma correlated with the use of topoisomerase II inhibitors, such as doxorubicin. The deoxyribonucleic acid-damaging activity of doxorubicin reinforced by the use of alkylating agents is highly suspected as a causative event in the development of leukemia after treatment of osteosarcoma. As the next step in the development of treatment for patients with osteosarcoma, the type and intensity of treatment must be evaluated to minimize possible leukemogenic effects without compromising the potential for cure.

AB - The current study describes two patients with osteosarcoma who had acute myeloid leukemia develop after treatment with multiagent chemotherapy. The incidence density for the chemotherapy protocol was 129.8 per 10,000 person-year of followup. Karyotype analysis of 16 reported patients (including the current two patients) indicated that most leukemias after treatment of osteosarcoma correlated with the use of topoisomerase II inhibitors, such as doxorubicin. The deoxyribonucleic acid-damaging activity of doxorubicin reinforced by the use of alkylating agents is highly suspected as a causative event in the development of leukemia after treatment of osteosarcoma. As the next step in the development of treatment for patients with osteosarcoma, the type and intensity of treatment must be evaluated to minimize possible leukemogenic effects without compromising the potential for cure.

UR - http://www.scopus.com/inward/record.url?scp=0034792623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034792623&partnerID=8YFLogxK

M3 - Article

C2 - 11603675

AN - SCOPUS:0034792623

SP - 239

EP - 246

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 391

ER -